These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 22645424)

  • 1. Hypertonic saline in treatment of pulmonary disease in cystic fibrosis.
    Reeves EP; Molloy K; Pohl K; McElvaney NG
    ScientificWorldJournal; 2012; 2012():465230. PubMed ID: 22645424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucus clearance and lung function in cystic fibrosis with hypertonic saline.
    Donaldson SH; Bennett WD; Zeman KL; Knowles MR; Tarran R; Boucher RC
    N Engl J Med; 2006 Jan; 354(3):241-50. PubMed ID: 16421365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nebulised hypertonic saline for cystic fibrosis.
    Wark PA; McDonald V
    Cochrane Database Syst Rev; 2000; (2):CD001506. PubMed ID: 10796798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhaled hypertonic saline as a therapy for cystic fibrosis.
    Elkins MR; Bye PT
    Curr Opin Pulm Med; 2006 Nov; 12(6):445-52. PubMed ID: 17053496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nebulised hypertonic saline for cystic fibrosis.
    Wark PA; McDonald V; Jones AP
    Cochrane Database Syst Rev; 2005 Jul; (3):CD001506. PubMed ID: 16034863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale for hypertonic saline therapy for cystic fibrosis lung disease.
    Tarran R; Donaldson S; Boucher RC
    Semin Respir Crit Care Med; 2007 Jun; 28(3):295-302. PubMed ID: 17562499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Model of mucociliary clearance in cystic fibrosis lungs.
    Kurbatova P; Bessonov N; Volpert V; Tiddens HA; Cornu C; Nony P; Caudri D;
    J Theor Biol; 2015 May; 372():81-8. PubMed ID: 25746843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nebulised hypertonic saline for cystic fibrosis.
    Wark PA; McDonald V
    Cochrane Database Syst Rev; 2003; (1):CD001506. PubMed ID: 12535409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertonic saline releases the attached small intestinal cystic fibrosis mucus.
    Ermund A; Meiss LN; Scholte BJ; Hansson GC
    Clin Exp Pharmacol Physiol; 2015 Jan; 42(1):69-75. PubMed ID: 25311799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altering airway surface liquid volume: inhalation therapy with amiloride and hyperosmotic agents.
    Hirsh AJ
    Adv Drug Deliv Rev; 2002 Dec; 54(11):1445-62. PubMed ID: 12458154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic options for hydrating airway mucus in cystic fibrosis.
    Tildy BE; Rogers DF
    Pharmacology; 2015; 95(3-4):117-32. PubMed ID: 25823699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhaled hypertonic saline in preschool children with cystic fibrosis (SHIP): a multicentre, randomised, double-blind, placebo-controlled trial.
    Ratjen F; Davis SD; Stanojevic S; Kronmal RA; Hinckley Stukovsky KD; Jorgensen N; Rosenfeld M;
    Lancet Respir Med; 2019 Sep; 7(9):802-809. PubMed ID: 31178421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restoring airway surface liquid in cystic fibrosis.
    Ratjen F
    N Engl J Med; 2006 Jan; 354(3):291-3. PubMed ID: 16421371
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis.
    Robinson M; Hemming AL; Regnis JA; Wong AG; Bailey DL; Bautovich GJ; King M; Bye PT
    Thorax; 1997 Oct; 52(10):900-3. PubMed ID: 9404379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydrator Therapies for Chronic Bronchitis. Lessons from Cystic Fibrosis.
    Bennett WD; Henderson AG; Donaldson SH
    Ann Am Thorac Soc; 2016 Apr; 13 Suppl 2(Suppl 2):S186-90. PubMed ID: 27115955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacotherapy of impaired mucociliary clearance in non-CF pediatric lung disease. A review of the literature.
    Boogaard R; de Jongste JC; Merkus PJ
    Pediatr Pulmonol; 2007 Nov; 42(11):989-1001. PubMed ID: 17902149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute inhalation of hypertonic saline does not improve mucociliary clearance in all children with cystic fibrosis.
    Laube BL; Sharpless G; Carson KA; Kelly A; Mogayzel PJ
    BMC Pulm Med; 2011 Sep; 11():45. PubMed ID: 21896198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overnight delivery of hypertonic saline by nasal cannula aerosol for cystic fibrosis.
    Corcoran TE; Godovchik JE; Donn KH; Busick DR; Goralski J; Locke LW; Markovetz MR; Myerburg MM; Muthukrishnan A; Weber L; Lacy RT; Pilewski JM
    Pediatr Pulmonol; 2017 Sep; 52(9):1142-1149. PubMed ID: 28737262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duration of action of hypertonic saline on mucociliary clearance in the normal lung.
    Bennett WD; Wu J; Fuller F; Balcazar JR; Zeman KL; Duckworth H; Donn KH; O'Riordan TG; Boucher RC; Donaldson SH
    J Appl Physiol (1985); 2015 Jun; 118(12):1483-90. PubMed ID: 25911685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dornase alfa for cystic fibrosis.
    Yang C; Chilvers M; Montgomery M; Nolan SJ
    Cochrane Database Syst Rev; 2016 Apr; 4():CD001127. PubMed ID: 27043279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.